High-intensity focused ultrasound for prostate cancer

A Napoli, G Alfieri, R Scipione, A Leonardi… - Expert review of …, 2020 - Taylor & Francis
High-intensity focused ultrasound (HIFU) is a noninvasive procedure that has shown
promising results in a wide range of malignant and nonmalignant conditions, including …

Emerging technology: applications of Raman spectroscopy for prostate cancer

RE Kast, SC Tucker, K Killian, M Trexler… - Cancer and Metastasis …, 2014 - Springer
There is a need in prostate cancer diagnostics and research for a label-free imaging
methodology that is nondestructive, rapid, objective, and uninfluenced by water. Raman …

Prevalence of major risk factors and use of screening tests for cancer in the United States

SA Fedewa, AG Sauer, RL Siegel, A Jemal - … Epidemiology, Biomarkers & …, 2015 - AACR
Much of the suffering and death from cancer could be prevented by more systematic efforts
to reduce tobacco use, improve diet, increase physical activity, reduce obesity, and expand …

Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer

RM Hoffman, T Koyama, KH Fan… - Journal of the …, 2013 - academic.oup.com
Background No randomized trials have compared survival outcomes for men with localized
prostate cancer (PC) being treated with radical prostatectomy (RP) or external beam …

[HTML][HTML] Cost-effectiveness analysis of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) for the primary …

R Song, V Jeet, R Sharma, M Hoyle, B Parkinson - Pharmacoeconomics, 2022 - Springer
Abstract Background and Objectives Prostate-specific membrane antigen (PSMA) positron
emission tomography (PET) combined with computed tomography (CT) is a new imaging …

[HTML][HTML] High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series

HU Ahmed, E Zacharakis, T Dudderidge… - British journal of …, 2009 - nature.com
Background: The use of minimally invasive ablative therapies in localised prostate cancer
offer potential for a middle ground between active surveillance and radical therapy …

[HTML][HTML] Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths

C Neppl-Huber, M Zappa, JW Coebergh, E Rapiti… - Annals of oncology, 2012 - Elsevier
Background We describe changes in prostate cancer incidence, survival and mortality and
the resulting impact in additional diagnoses and avoided deaths in European areas and the …

Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy

MR Cooperberg, S Hinotsu, M Namiki, K Ito… - Journal of clinical …, 2009 - ascopubs.org
Purpose Prostate cancer epidemiology has been marked overall by a downward risk
migration over time. However, in some populations, both in the United States and abroad …

[HTML][HTML] Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

FC Hamdy, JL Donovan, JA Lane… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Prostate cancer is the most common cancer among men in the UK. Prostate-
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …

Primary whole-gland ablation for the treatment of clinically localized prostate cancer: a focal therapy society best practice statement

S Deivasigamani, S Kotamarti, AR Rastinehad… - European urology, 2023 - Elsevier
Context Whole-gland ablation is a feasible and effective minimally invasive treatment for
localized prostate cancer (PCa). Previous systematic reviews supported evidence for …